Table 2 Results on total and allergic/non-allergic drug costs by year after SCITonset (analytic) – not involving SCIT intervention costs
Years after SCIT onset | SCIT | Control | p-value |
|---|---|---|---|
Total drug costs in euro [mean (95% CI)] | |||
1. year | 319 (236 to 402) | 364 (262 to 466) | 0.716 |
2. year | 250 (168 to 333) | 389 (272 to 506) | 0.077 |
3. year | 193 (114 to 273) | 498 (293 to 702) | 0.001 |
Allergic drug costs in euro [mean (95% CI)] | |||
1. year | 270 (197 to 343) | 306 (219 to 393) | 0.716 |
2. year | 206 (135 to 277) | 341 (232 to 451) | 0.021 |
3. year | 168 (94 to 242) | 453 (249 to 656) | 0.002 |
Non-Allergic drug costs in euro [mean (95% CI)] | |||
1. year | 49 (24 to 75) | 58 (16 to 100) | 0.233 |
2. year | 44 (13 to 75) | 47 (7 to 88) | 0.262 |
3. year | 25 (2 to 48) | 45 (0 to 92) | 0.373 |